"Intermediate care units are the newest trend in health policy, and...
Category:
Health
Latest
Over 1.3 billion people globally to have diabetes by 2050, finds study
Addressing racism and economic inequality will be important for...
Delta variant, a warning the COVID-19 virus is getting ‘fitter and faster’
Tedros Adhanom Gebreyesus,Director-General, WHO Almost 4 million...
Pfizer vaccine worries Norway as 29 elderly people die after taking shot
Official reports of allergic reactions have been rare as governments rush to roll out vaccines to try to contain the global pandemic. U.S. authorities reported 21 cases of severe allergic reactions from Dec. 14-23 after administration of about 1.9 million initial doses of the Pfizer vaccine. The first Europe-wide safety report on the Pfizer-BioNTech vaccine is due to be published at the end of January.
2,24,301 beneficiaries given COVID-19 vaccine so far; 447 cases of adverse effect reported: Govt
Addressing a press briefing, the ministry”s Additional Secretary Manohar Agnani said out of the 447 adverse events following immunisation, only three required hospitalisation
Metropolis Healthcare to acquire Hitech Diagnostic Centre in a cash, stock deal
By the acquisition, Metropolis will get an access to 31 laboratories, including three NABL- and ICMR-accredited laboratories and 68 collection centres of Hitech. The acquisition is expected to be completed within three months, it added.
Metropolis Healthcare Managing Director Ameera Shah said, “In line with the strategy to grow, gain market share and increase B2C (business-to-consumer) revenues in focus cities, we are acquiring Hitech Diagnostic Centre which will strengthen our leadership position in the South India market.”
German specialists probing 10 deaths of people vaccinated against Covid-19
The institute also reported six anaphylaxis cases. So far, there have been 325 cases of side-effects allegedly related to the vaccine, including 51 severe ones. Keller-Stanislawski stated that those results are within expectations and correspond to the US vaccination statistics.
UK begins major trial for new inhaler-based Covid-19 treatment
“We need treatments as well as vaccines to fight highly pathogenic viruses such as SARS-CoV-2 [Covid-19]. Development of treatments like ours will remain necessary in cases where vaccines are not effective, for those who do not get vaccinated, and in case the virus mutates to the point where vaccines become less effective,” said Richard Marsden, CEO of Synairgen.
India records 15,144 fresh COVID-19 cases
The death toll increased to 1,52,274 with 181 more fatalities, the data updated at 8 am showed.
There are 2,08,826 active cases of coronavirus infection in the country which constitute 1.98 per cent of the total caseload, the data showed.
Russia to reopen air travel with Finland, Vietnam, India and Qatar – government
A statement shared following a meeting of the government’s coronavirus HQ said that the four countries were seeing fewer than 40 new cases per fortnight per 100,000 people.
FPIs invest Rs 14,886 cr in first half of January
The strong flows are on account of the positive bias towards emerging markets and because of strong third-quarter earnings thus far besides decreasing domestic COVID-19 cases, said Rusmik Oza, executive vice president, head of fundamental research at Kotak Securities.
The forthcoming US stimulus could be another trigger for positive FPI bias towards emerging markets and India, he added.
”Going ahead, the market could be volatile given the ongoing earning season and the weak global cues. Run-up to the Budget would also add to the volatility,” said Siddhartha Khemka, Head – Retail Research, Motilal Oswal Financial Services Ltd.
WhatsApp delays new privacy policy by three months amid severe criticism
“We’ve heard from so many people how much confusion there is around our recent update. There’s been a lot of misinformation causing concern and we want to help everyone understand our principles and the facts,” WhatsApp said in a company blog.
India kicks off ‘world’s largest’ vaccination campaign
India, the world’s most populous country after China, has said it may not need to vaccinate all of its 1.35 billion people to create herd immunity. Still, covering even half its population will make it one of the largest immunisation programmes in the world, even if countries like the United States were to vaccinate every resident.